FLAGSHIP VENTURES FUND 2007, L.P.
Follow13F filer, CIK 1508052, CAMBRIDGE, MA
FLAGSHIP VENTURES FUND 2007, L.P. reported $95,217,000 across 4 holdings for the quarter ended 2016-03-31, in a 13F-HR/A filed 2016-06-03.
Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0000950123-16-017853
- Period
- 2016-03-31
- Reported value
- $95.2M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q1 2016
Share positions as resolved from 13F-HR/A 0000950123-16-017853, largest first. % of portfolio is the value over $95,217,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| AGIOAGIOS PHARMACEUTICALS INC | 1,930,369 | $78.4M | 82.31% | Timeline | |||
| SERES THERAPEUTICS INCSERES THERAPEUTICS INC | 599,297 | $15.9M | 16.72% | ||||
| SESEN BIO, INC.SESEN BIO, INC. | 1,907,008 | $610K | 0.64% | ||||
| RENEWABLE ENERGY GROUP INCRENEWABLE ENERGY GROUP INC | 33,570 | $317K | 0.33% |
How Q1 2016 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001012975-16-001222 | superseded | 2016-05-13 | acceptance time not in the bulk data set | ||
| 13F-HR/A 0000950123-16-017853 | base | restatement | 2016-06-03 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR/A 0000950123-16-017853 | Quarter ended 2016-03-31 | 2016-06-03 | acceptance time not in the bulk data set | |
| 13F-HR 0001012975-16-001222 | Quarter ended 2016-03-31 | 2016-05-13 | acceptance time not in the bulk data set |